Abstract
This interesting and informative chapter provides an overview of the pathophysiology of movement disorders in children. Surgical management is discussed, including intrathecal pumps, deep brain stimulators (DBS), and dorsal rhizotomy. Nursing care and informative parental insights are presented.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abbott R (1999). Selective dorsal rhizotomy. Retrieved August 16, 2005, from http://cerebnet.netfirms.com/selective.htm
Adams M, Hicks AL (2010) Spasticity: pathophysiology, assessment, and management. In: Lin VW (ed) Spinal cord medicine: principles and practice. Demos Medical Publishing, New York
Albanese A, Barnes MP, Bhatia KP, Fernandez-Alvarez E, Fillipini G, Gasser T et al (2006) A systematic review on the diagnosis and treatment of primary (idiopathic) dystonia and dystonia plus syndromes: report of an EFNS/MDS-ES task force. Eur J Neurol 13(5):433–444. doi:10.1111/j.1468-1331.2006.01537.x
Albanese A, Bhatis K, Bressman SB, Delong MR, Fahn A, Fung VSC et al (2013) Phenomenology and classification of dystonia: a consensus update. Mov Disord 28(7):863–873
Albright AL (2003) Neurosurgicaltreatment of spasticity and other pediatric movement disorders, J. chid Neurol 18:S67–S78
Albright AL, Ferson SS (2006) Intrathecal baclofen therapy in children. Neurosurg Focus 21(2):1–6
Atiyeh BS, Hayek SN, Skaf GS, Araj AA, Chamoun RB (2006) Baclofen pump pocket infection: a case report of successful salvage with muscle flap. Int Wound J 3:23–28
Awaad Y, Tayem H, Munoz S, Ham S, Michon AM, Awaad R (2003) Functional assessment following intrathecal Baclofen therapy in children with spastic cerebral palsy. J Child Neurol 18:26–34
Awan NR, Lozano A, Hamani C (2009) Deep brain stimulation: current and future perspectives. Neurosurg Focus 27(1). doi:10.3171/2009.4.FOCUS0982
Barry MJ, Van Swearingen JM (1999) Reliability and responsiveness of the Barry-Albright Dystonia Scale. Dev Med Child Neurol 41(6):404–411
Berardelli A, Rothwell JC, Hallett M, Thompson PD, Manfredi M, Marsden CD (1998) The pathophysiology of primary dystonia. Brain 121:1195–1212
Bergenheim AT, Wendelius M, Shahidi S, Larsson E (2003) Spasticity in a child with myelomeningocele treated with continuous intrathecal Baclofen. Pediatr Neurosurg 39:218–221. doi:10.1159/000072476
Boviatsis EJ, Kouyialis AT, Boutsikakis I, Korfas S, Sakas DE (2004) Infected CNS infusion pumps: is there a chance for treatment without removal? Acta Neurochir 146:463–467
Camargo CH, Camargos ST, Cardoso FEC, Teive HAG (2015) The genetics of the dystonias – a review based on the new classification of the dystonias. Arq Neuropsiquiatr 73(4):350–358. doi:10.1590/0004-282XX20150030
Center for Disease Control and Prevention; Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR (1999) The Hospital Infection Control Practice Advisory Committee. Guideline for prevention of surgical site infection. Infection control and Hospital Epidemiology 20(4):247–278
Cheek WR (1996) Atlas of pediatric neurosurgery. W.B. Saunders Company, Philadelphia
Comella CL, Leurgans S, Wuu J, Stebbins GT, The Dystonia Study Group (2003) Rating scales for dystonia: a multicenter assessment. Mov Disord 18(3):303–312
Danner SM, Dimitrijevic MR (2012) Spasticity: pathophysiology and neural control. In: Kusimastuli P, Tular ABM (eds) 3rd Asia-Oceanian Conference of Physical and Rehabilitation Medicine in Conjunction with XI Annual Scientific of Indonesian Association of Physical Medicine and Rehabilitation. Medimond, Bologna ISBN978–88–7587-655-5, pp 9–15
Dario A, Tomei G (2004) A benefit-risk assessment of Baclofen in severe spinal spasticity. Drug Saf 27(11):799–818
Dario A, Scamoni C, Picano M, Fortini G, Cuffari A, Tomei G (2005) The infection risk of intrathecal drug infusion pumps after multiple refill procedures. Neuromodulation 8(1):36–39
Dawes WJ, Drake JM, Fehlings D (2003) Microfracture of a baclofen pump catheter with intermittent under- and overdose. Pediatr Neurosurg 39(3):144–148
Dietz V (2000) Spastic movement disorder. Spinal Cord 38:389–393
DiFrancesco MF, Halpern CH, Hurig HH, Raltuch GH, Heuer GG (2012) Pediatric indications for deep brain stimulation. Childs Nerv Syst 28:1701–1714
Douglas AF, Weiner HL, Schwartz DR (2005) Prolonged intrathecal baclofen withdrawal syndrome. J Neurosurg 102:1133–1136
Fenoy AJ, Simpsons R (2014) Risks of common complication in deep brain stimulation surgery: management and avoidance. J Neurosurg 120:132–139
Fitzgerald JJ, Tsegaye M, Vloeberghs (2004) Treatment of childhood spasticity of cerebral origin with intrathecal Baclofen: a series of 52 cases. Br J Neurosurg 18(3):240–245
Follett KA, Burchiel K, Deer T, Dupen S, Prager J, Turner MS et al (2003) Prevention of intrathecal drug delivery catheter-related complications. Neuromodulation 6(1):32–41
Geyer HL, Bressman SB (2006) The diagnosis of dystonia. Lancet Neurol 5(9):780–790. doi:10.1016/S1474-4422(06)70547-6
Goldstein EM (2001) Spasticity management : an overview. J Child Neurol 16:16–23
Gooch JL, Oberg WA, Grams B, Ward LA, Walker ML (2003) Complications of intrathecal Baclofen pumps in children. Pediatr Neurosurg 39:1–6
Grunt S, Becher JG, Vermeulen RJ (2011) Long-term outcome and adverse effects of selective dorsal rhizotomy in children with cerebral palsy: a systematic review. Dev Med Child Neurol 53:490–498. doi:10.1111/j.469-8749.2011.03912.x
Guettard E, Roze E, Abada G, Lemesle C, Vidailhet M, Laurent-Vannier A et al (2009) Management of spasticity and dystonia in children with acquired brain injury with rehabilitation and botulinum toxin A. Dev Neurorehabil 12(3):128–138. doi:10.1080/17518420902927994
Haranhalli N, Amnand D, Wisoff JH, Harter DH, Weiner HL, Blate M, Roth J (2010) Intrathecal baclofen therapy: complication avoidance and management. Childs Nerv Syst 27:421–427. doi:10.1007/s00381-010-1277-9
Hays RM, McLaughlin JF, Geiduschek JM, Bjornson KF,Graubert CS (1997) Evaluation of the effects of selective dorsal rhizotomy. Mental retardation and Development Disabilities Research Reviews, 3:168–174
Hippard HK, Watcha M, Stocco AJ, Curry D (2014) Preservation of microelectrode recordings with non-GABAergic drugs during deep brain stimulator placement in children. J Neurosurg Pediatr 14:279–286
Hesselgard K, Reinstrup P, Stromblad LG, Unden J, Romner B (2005) Selective dorsal rhizotomy and postoperative pain management. Pediatr Neurosurg 43:107–112. doi:10.1159/000098382
Institute for Neurology & Neurosurgery (2004). Rhizotomy. Retrieved August 16, 2005, from http://nyneruosurgery.org/cp/thizhist.html
Keen JR, Przekop A, Olaya JE, Zouros A, Hsu FP (2014) Deep brain stimulation for the treatment of childhood dystonic cerebral palsy. J Neurosurg Pediatr 14(6):585–93. doi:10.3171/2014.8.PEDS141
Keenan E (2010) Spasticity management, Part 3: surgery and the use of intrathecal baclofen. Br J Neurosci Nurs 6(1):12–18
Kenney C, Simpson R, Hunter C, Ondo W, Almaguer M, Davidson A, Jankovic J (2007) Short-term and long-term safety of deep brain stimulation in the treatment of movement disorders. J Neurosurg 106:621–625
Krach LE, Kriel R, Day SM, Strauss DJ (2009) Survival of individual with cerebral palsy receiving continuous intrathecal baclofen treatment: a matched-cohort study. Dev Med Child Neurol 52:672–676. doi:10.1111/j.1469-8749.2009.03473.x
Koman LA, Smith B, Balkrishnan (2003) Spasticity associated with cerebral palsy in children. Pediatr Drug 5(1):11–23
Larson PS, Richardson RM, Starr PA, Martin AJ (2008) Magnetic resonance imaging of implanted deep brain stimulators: experience in a large series. Stereotact Funct Neurosurg 28:92–100
Lipsman N, Ellis M, Lozano AM (2010) Current and future indications for deep brain stimulation in pediatric populations. Neurosurg Focus 29(2):1–7
Lubarr N, Bressman S (2010) Advances in our understanding of dystonia – pathophysiology and treatment outcome. US Neurol 6(2):115–121. doi:10.17925/USN.2010.06.02.115
Madhusudanan M (1999) Dystonia: emerging concepts in pathophysiology. Neurol India 47:263
MacWilliam BA, Johnson BA, Shuckra AL, D’Astous JL (2011) Functional decline in children undergoing selective dorsal rhizotomy after age 10. Dev Med Child Neurol 53:717–723. doi:10.1111/j.1469-8749.2011.04010.x
Martins A (2016) The role of spasticity in functional neurorehabilitation – Part 1: the pathophysiology of spasticity, the relationship with neuroplasticity, spinal shock and clinical signs. Arch Medication 8(3):1–7
Martin AJ, Larson PS, Ziman N, Levesque N, Volz M, Ostrem JL, Starr PA (2016) Deep brain stimulator implantation in a diagnostic MRI suite: infection history over a 10-year period. J Neurosurg, Published online March 25, 2016; doi:10.3171/2015.7.JNS15750
Medtronic Inc (2015) MRI guidelines for Medtronic deep brain stimulation systems, 2014-12-01 - instructions for use. http://www.zaloker-zaloker.si/assets/Uploads/MR-smernice.pdf
Mohammed I, Hussain A (2004) Intrathecal baclofen withdrawal syndrome – a life-threatening complication of baclofen pump: a case report. BMC Clin Pharmacol 4(6):1–5. doi:10.1186/1472-6904-4-6
Morton RE, Gray N, Vloeberghs M (2011) Controlled study of the effects of continuous intrathecal baclofen infusion in non-ambulant children with cerebral palsy. Dev Med Child Neurol 53:736–741. doi:10.1111/j1469-8749.2011.04009.x
Moss SD, Manwaring KH (1992) Relief of spasticity for children with cerebral palsy using selective posterior rhizotomy. Phoenix Child Hosp Pediatr Rev 4(1):5–11
Motta F, Buonaguro V, Stignani C (2007) The use of intrathecal baclofen pump implants in children and adolescents: safety and complications in 200 consecutive cases. J Neurosurg 107:32–35. doi:10.3171/PED-07/07/032
Mullarkey T (2009) Considerations in the treatment of spasticity with intrathecal baclofen. Am J Health-Syst Pharm 66(Suppl. 5):s14–s22. doi:10.2146/ajhp0108c
Kumura A, Kidokoro H, Shoji H, Nakazawa T, Mimaki M, Fujil K et al (2009) Kernicterus in preterm infants. Pediatrics 123:1052–1058. doi:10.1542/peds.2008.2791
Olaya JE, Christian E, Ferman D, Luc Q, Krieger MD, Sanger TD, Liker MA (2013) Deep brain stimulation in children and young adults with secondary dystonia: the Children’s Hospital Los Angeles experience. Neurosurg Focus 35(5):1–13
Ou C, Kent S, Miller S, Steinbok P (2010) Selective dorsal rhizotomy in children: comparison of outcomes after single-level versus multi-level laminectomy technique. Can J Neurosci Nurs 32(3):17–24
Pin TW, McCartney L, Lewis J, Waugh M (2011) Use of intrathecal baclofen therapy in ambulant children and adolescents with spasticity and dystonia of cerebral origin: a systematic review. Dev Med Child Neurol 53:885–895. doi:10.1111/j.1469-8749.2011.03992.x
Plassat R, Verbe BP, Menei P, Menegalli D, Mathe JF, Richard I (2004) Treatment of spasticity with intrathecal Baclofen administration: long-term follow-up, review of 40 patients. Spinal Cord 42:686–693
Priori F, Cogiamanian f, sPposta SM (2006)Pathophysiology of spasticity. Vol 27 supplement 4, s307–s309
Ramstad K, Jahnsen R, Lofterod B, Skjeldal OH (2010) Continuous intrathecal baclofen therapy in children with cerebral palsy – when does improvement emerge? Acta Paediatr 99:1661–1665. doi:10.1111/j.1651-2227.2009.01596x
Rekand T (2010) Clinical assessment and management of spasticity: a review. Acta Neurol Scand Suppl (190):62–66. doi:10.1111/j.1600-0404.2010.01378.x
Roubertie A, Echonne B, Cif L, Vayssiere N, Hemm S, Coubes P (2000) Treatment of early-onset dystonia: update and a new perspective. Childs Nerv Syst 16:334–340
Ridley B, Rawlins PK (2006) Intrathecal baclofen therapy: ten steps toward best practice. J Neurosci Nurs 38(2):72–82
Rizzo MA, Hadjimichael OC, Preinigherova J, Vollmer TL (2004) Prevalence and treatment of spasticity reported by multiple sclerosis patients. Mult Scler 10:589–595
Rose J, Vassar R (2015) Movement disorders due to bilirubin toxicity. Semin Fetal Neonatal Med 20(1):20–25. doi:10.1016/j.siny.2014.11.002
Satkunam LE (2003) Rehabilitation medication: 3. Management of adult spasticity. CMAJ 169(11):1173–1179
Sheean G (2002) The pathophysiology of spasticity. Eur J Neurol 9(Suppl. 1):3–9
Stallings VA, Cronk CE, Zemel BS, Charney EB (1995) Body composition in children with spastic quadriplegic cerebral palsy. J Pediatr 126:833–839
Steinbok P (2006) Selection of treatment modalities in children with spastic cerebral palsy. Neurosurg Focus 21(2):1–8. doi:10.317/foc.2006.21.2.5
Steinbok P, Tidemann AJ, Miller S, Mortenson P, Bowen-Roberts T (2009) Electrophysiologically guided versus non-electrophysiologically guided selective dorsal rhizotomy for spastic cerebral palsy: a comparison of outcomes. Childs Nerv Syst 25:1091. doi:10.1007/s00381-009-0908-5
Tabbal SD (2015) Childhood dystonias. Curr Treat Options Neurol 17(12):1–15. doi:10.1007/s11940-015-0339-4
Tedroff K, Lowing K, Jacobson DN, Astrom E (2011) Does loss of spasticity matter? a 10-yer follow-up after selective dorsal rhizotomy in cerebral palsy.Dev Med Child Neurol. 53(8):724–729, doi:10.1111/j.1469-8749-2011.03969.x
Tempel LW, Perlmutter JS (1993) Abnormal cortical responses in patients with writer’s cramp. Neurology 43:2252–2257
Thompson AJ, Jarrett L, Lockley L, Marsden J, Stevenson VL (2005) Clinical management of spasticity. J Neurol Neurosurg Psychiatry 76:459–463. doi:10.1136/jnnp.2004.035972
Trompetto C, Marinelli L, Mori L, Pelosin E, Curra A, Molfetta L, Abbruzzes G (2014) Pathophysiology of spasticity - implication for neurorehabilitation. BioMed Research International. Volume 2014, http://dx.doi: org/10.1155/2014/354906
Vanek ZF, Menkes JH, Carcione J, Talavera F, Lopate G, Benbadis S, Berman SA (2010) Spasticity. eMedicine Neurology. Retrieved January 21, 2012, from http://www.emedicine.com/neuro/topic706.htm
Vayssiere N, Hemm S, Zancel M, Picot MC, Bonafe A, Cif L et al (2000) Magnetic resonance imaging stereotactic target localization for deep brain stimulation in dystonic children. J Neurosurg 93:784–790
Vender LR, Hester S, Rekito A, Lee MR (2005) Baclofen intrathecal pump delivery systems, avoidance and management of complications in adult and pediatric patients: part 2. Contemp Neurosurg 27(2):1–5
Verceuil L, Krack P, Pollak P (2002) Results of deep brain stimulation for dystonia: a critical reappraisal. Mov Disord 17(S3):S89–S93. doi:10.1002/mds.10148
Vitztum C, Olney B (2000) Intrathecal baclofen therapy and the child with cerebral palsy. Orthop Nurs 19(1):43–48
Ward A, Hayden S, Dexter M, Scheinberg (2009) Continuous intrathecal baclofen for children with spasticity and/or dystonia: goal attainment and complications associated with treatment. J Paediatr Child Health 45:72–726. doi:10.1111/j.1440-1754.2009.01601.x
Ward AB, Molenaers G, Colosimo C, Berardelli A (2006) Clinical value of botulinum toxin in neurological indications. Eur J Neurol 13(Suppl. 4):20–26
Watve SV, Sivan M, Raza WA, Jamil FF (2012) Management of acute overdose or withdrawal state in intrathecal baclofen therapy. Spinal Cord 50:107–111
Wong V (2003) Evidence-based approach of the use of botulinum toxin A (BTX) in cerebral palsy. Pediatr Rehabil 6(2):85–96. doi:10.1080/1363849031000139306
Yam WKL, Leung MSM (2006) Interrater reliability of modified Ashworth scale and modified Tardieu Scale in children with spastic cerebral palsy. J Child Neuol. 21:1031–1035. doi:10.23107010.2006.00222
Yu H, Neimat JS (2008) The treatment of movement disorders by deep brain stimulation. 89u. J Am Soc Exp Neurother 5:26–36
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Yu, H. (2017). Surgical Management of Functional Disorders. In: Cartwright, C., Wallace, D. (eds) Nursing Care of the Pediatric Neurosurgery Patient. Springer, Cham. https://doi.org/10.1007/978-3-319-49319-0_14
Download citation
DOI: https://doi.org/10.1007/978-3-319-49319-0_14
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-49318-3
Online ISBN: 978-3-319-49319-0
eBook Packages: MedicineMedicine (R0)